HOPCo Expands its Musculoskeletal Population Health Program with Humana Partnership and its Arizona Members

Rhea-AI Summary

HOPCo and Humana (NYSE: HUM) announced a partnership effective Oct. 28, 2025 to add eligible Humana members in Arizona to HOPCo's musculoskeletal (MSK) population health platform.

HOPCo will deploy its Integrated Care System (ICS), digital engagement tools including myrecovery, and its statewide HOPCo Specialty Care Network (HSCN) to connect members, primary care providers, and more than 230 MSK specialty physicians in Arizona under evidence-based protocols. HSCN is described as the only URAC-accredited MSK CIN in the U.S. The release also notes HOPCo's recent acquisition of AI-powered digital health company Caro Health.

Positive

• Partnership adds Humana Arizona members to HOPCo MSK platform (Oct 28, 2025)
• HSCN aligned 230+ MSK specialty physicians across Arizona
• URAC-accredited status: only MSK CIN with URAC accreditation in the U.S.
• Integrated Care System plus myrecovery digital tools and omnichannel care

Negative

• None.

HOPCo's unique specialty care platform, empowered with integrated analytics and member engaging digital tools, will align providers and members around clinical best practices and is now available for eligible Humana members receiving musculoskeletal (MSK) care across Arizona.

PHOENIX, Oct. 28, 2025/PRNewswire/ -- Healthcare Outcomes Performance Company (HOPCo), the global leader in integrated MSK value-based care solutions, MSK physician practice management, and specialty care clinically integrated networks, and leading health and well-being company, Humana Inc. (NYSE: HUM), have partnered to add Humana members in Arizona to HOPCo's advanced MSK population health solution. This partnership is designed to advance quality of care and help optimize patient health outcomes for eligible individuals living with musculoskeletal conditions.

HOPCo's proprietary platform, which includes integrated provider and patient digital engagement solutions, a comprehensive evidence-based care delivery infrastructure, and proven value-based care medical economics platform, is being deployed to a growing population of payors and members. HOPCo will use its digitally powered Integrated Care System (ICS) ensuring members with MSK conditions rapidly receive the correct therapies and care management with the most appropriate provider and in the most appropriate setting, all while being guided and monitored by MSK clinical experts adhering to evidence-based protocols through a unique combination of omnichannel in-person, virtual, and hybrid interactions.

Unlike point solutions that often focus on a limited portion of the patient journey, HOPCo's value-based care platform engages members and providers across the entire MSK care continuum at all points of care. The platform utilizes proprietary digital engagement tools including  myrecovery ^® , to engage members fully upstream with primary care providers (PCPs) as well as with MSK specialists through HOPCo's statewide clinically integrated network (CIN ), the HOPCo Specialty Care Network (HSCN) . HSCN, the only URAC-accredited MSK CIN in the country, has aligned more than 230 MSK specialty physicians across Arizona around clinical best practices, quality incentive metrics, and real-time claims analytics. Further underscoring HOPCo's continued growth of its fully integrated digital solutions, the company recently announced the acquisition of AI-powered digital health leader, Caro Health.

"We continue to see great enthusiasm from payors and risk-bearing entities for HOPCo's proven solutions that engage members and all stakeholders aligning care around evidence-based best practices across all points of the patient journey," said Jason Scalise, MD, Chief Value Officer at HOPCo. "Our dedicated upstream PCP engagement platform combined with our statewide MSK specialty CIN, fully integrated digital engagement tools and sophisticated medical economics and analytics is far more effective than isolated point solutions. It is instead, a solution for every point of care." Additional payors and risk bearing entities in Arizona and across the US have engaged with HOPCo for similar large scale and durable MSK care solutions, he added.

About Healthcare Outcomes Performance Company (HOPCo) 
Healthcare Outcomes Performance Company (HOPCo) is the global leader in musculoskeletal (MSK) value-based care, outcomes management, and care transformation. HOPCo partners with physician practices, health systems, payors, and suppliers to implement clinically integrated models that improve quality, reduce variability, and lower the total cost of MSK care.

Through HOPCo Digital, its advanced technology and AI platform, HOPCo is building the most comprehensive solution for practices, ambulatory surgery centers, payors, suppliers, and health systems enabling integrated, data-driven, and patient-centered care. HOPCo's global footprint includes partnerships worldwide, with teams on the ground supporting successful implementations in both emerging and mature healthcare systems and markets.

Visit www.hopco.com to learn more.
Follow us on LinkedIn, Instagram and Facebook

View original content to download multimedia:https://www.prnewswire.com/news-releases/hopco-expands-its-musculoskeletal-population-health-program-with-humana-partnership-and-its-arizona-members-302596790.html

SOURCE Healthcare Outcomes Performance Company

FAQ

What did HOPCo and Humana (HUM) announce on October 28, 2025 regarding Arizona members?

They announced a partnership to add eligible Humana members in Arizona to HOPCo's MSK population health platform.

How many MSK specialty physicians are aligned with HOPCo's HSCN in Arizona?

HOPCo says its HSCN has aligned more than 230 MSK specialty physicians across Arizona.

What digital tools will HOPCo use for Humana (HUM) members in Arizona?

HOPCo will deploy its Integrated Care System (ICS) and digital engagement tools including myrecovery for omnichannel care.

Does the HOPCo–Humana partnership cite any clinical accreditation for the network?

Yes; HOPCo describes HSCN as the only URAC-accredited MSK clinically integrated network in the country.

Did HOPCo mention any recent acquisitions alongside the Humana (HUM) partnership?

Yes; the company referenced its recent acquisition of AI-powered digital health leader Caro Health.

What is the stated goal of HOPCo's MSK program for Humana (HUM) members in Arizona?

The program aims to advance quality of care and optimize health outcomes for eligible individuals living with musculoskeletal conditions.